<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Can J Vet Res</journal-id><journal-id journal-id-type="iso-abbrev">Can. J. Vet. Res</journal-id><journal-id journal-id-type="pmc-domain-id">133</journal-id><journal-id journal-id-type="pmc-domain">cjvetres</journal-id><journal-title-group><journal-title>Canadian Journal of Veterinary Research</journal-title></journal-title-group><issn pub-type="ppub">0830-9000</issn><issn pub-type="epub">1928-9022</issn><publisher><publisher-name>Canadian Veterinary Medical Association</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC4581676</article-id><article-id pub-id-type="pmcid-ver">PMC4581676.1</article-id><article-id pub-id-type="pmcaid">4581676</article-id><article-id pub-id-type="pmcaiid">4581676</article-id><article-id pub-id-type="pmid">26424912</article-id><article-id pub-id-type="publisher-id">cjvr_10_309</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Hemodynamic effects of target-controlled infusion of propofol alone or in combination with a constant-rate infusion of remifentanil in dogs</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Beier</surname><given-names initials="SL">Suzane L.</given-names></name><xref ref-type="corresp" rid="c1-cjvr_10_309"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mattoso</surname><given-names initials="CRS">Cl&#225;udio R.S.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Aguiar</surname><given-names initials="AJA">Antonio J.A.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Vianna</surname><given-names initials="PTG">Pedro T.G.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Massone</surname><given-names initials="F">Flavio</given-names></name></contrib><aff id="af1-cjvr_10_309">Department of Clinical and Veterinary Surgery, School of Veterinary Medicine, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil (Beier); Department of Veterinary Medicine, School of Veterinary Medicine, Agricultural and Animal Sciences, Santa Catarina State University, Lages, Santa Catarina, Brazil (Mattoso); Department of Veterinary Surgery and Anesthesiology, School of Veterinary Medicine and Animal Science, (Aguiar, Massone), and Department of Anesthesiology, School of Medicine, S&#227;o Paulo State University, Botucatu, S&#227;o Paulo, Brazil (Vianna).</aff></contrib-group><author-notes><corresp id="c1-cjvr_10_309">Address all correspondence to Dr. Suzane L. Beier; telephone: 55 (31) 3409-2229; fax: 55 (31) 3409-2230; e-mail: <email>suzanelb@yahoo.com.br</email></corresp></author-notes><pub-date pub-type="ppub"><month>10</month><year>2015</year></pub-date><volume>79</volume><issue>4</issue><issue-id pub-id-type="pmc-issue-id">258276</issue-id><fpage>309</fpage><lpage>315</lpage><history><date date-type="received"><day>21</day><month>7</month><year>2014</year></date><date date-type="accepted"><day>19</day><month>11</month><year>2014</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>04</month><year>2016</year></date></event><event event-type="pmc-live"><date><day>01</day><month>04</month><year>2016</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2016-04-01 00:13:37.640"><day>01</day><month>04</month><year>2016</year></date></event></pub-history><permissions><copyright-statement>Copyright and/or publishing rights held by the Canadian Veterinary Medical Association</copyright-statement><copyright-year>2015</copyright-year></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="cjvr_10_309.pdf"/><abstract><p>The objective of this study was to evaluate the hemodynamic effects of target-controlled infusion (TCI) of propofol alone or in combination with a constant-rate infusion (CRI) of remifentanil. Six adult dogs were given 2 treatments in a randomized crossover study with a 7-day interval between treatments. Treatment 1 was propofol (P) and treatment 2 was propofol and remifentanil (P-Rem), without any premedication. Propofol was induced using a TCI system with a predicted plasma concentration (Cp) of 6.0 &#956;g/mL. Anesthesia was maintained within the Cp range (0.65 to 3.0 &#956;g/mL) for 120 min and remifentanil was administered at a rate of 0.3 &#956;g/kg body weight (BW) per minute, CRI. Cardiopulmonary variables were recorded before (baseline), during, and 120 min after drug administration. Heart rate (HR) decreased significantly in the P-Rem group (46%) compared with baseline values. In the P-Rem group, the cardiac index (CI) decreased significantly (49% to 58%) and the stroke volume (SV) decreased compared with baseline values. The systemic vascular resistance index (SVRI) increased significantly in the P-Rem group compared with baseline values. There was no difference in mean arterial pressure (MAP) between the groups. Central venous pressure (CVP) and pulmonary artery occlusion pressure (PAOP) significantly increased in the P-Rem group compared with baseline values. In conclusion, the hemodynamic changes observed in this study indicate a compromise of the cardiovascular system, although the dogs in this study were healthy/euvolemic and there was no change in preload. More studies are required in order to evaluate the actual safety of the combination of propofol and remifentanil in patients with reduced cardiac reserve.</p></abstract><trans-abstract xml:lang="fr"><title>R&#233;sum&#233;</title><p>L&#8217;objectif de la pr&#233;sente &#233;tude &#233;tait d&#8217;&#233;valuer les effets h&#233;modynamiques d&#8217;une infusion &#224; objectif de concentration (IOC) de propofol uniquement ou en combinaison avec une infusion &#224; d&#233;bit constant (IDC) de remifentanyl. Six chiens adultes re&#231;urent deux traitements dans un essai al&#233;atoire crois&#233; avec un intervalle de sept jours entre les traitements. Le traitement 1 consistait en du propofol (P) et le traitement 2 &#233;tait du propofol et du remifentanyl (P-Rem), sans aucune pr&#233;m&#233;dication. Le propofol fut induit &#224; l&#8217;aide d&#8217;un syst&#232;me d&#8217;IOC avec une concentration plasmatique pr&#233;d&#233;termin&#233;e (Cp) de 6,0 mg/mL. L&#8217;anesth&#233;sie fut maintenue &#224; l&#8217;int&#233;rieur de l&#8217;&#233;cart de Cp (0,65 &#224; 3,0 &#956;g/mL) pendant 120 min et du remifentanyl administr&#233; &#224; un taux de 0,3 &#956;g/kg de poids corporel (PC) par minute, IDC. Les variables cardiopulmonaires furent enregistr&#233;es avant (valeurs de base), pendant, et 120 min apr&#232;s l&#8217;administration des m&#233;dicaments. Le rythme cardiaque (RC) a diminu&#233; significativement dans le groupe P-Rem (46 %) comparativement aux valeurs de base. Dans le groupe P-Rem, l&#8217;index cardiaque (IC) a diminu&#233; significativement (49 % &#224; 58 %) et le volume du d&#233;bit systolique (VDS) a diminu&#233; comparativement aux valeurs de base. L&#8217;index de r&#233;sistance vasculaire syst&#233;mique (IRVS) a augment&#233; de mani&#232;re significative dans le groupe P-Rem comparativement aux valeurs de base. Il n&#8217;y avait aucune diff&#233;rence entre les groupes pour la pression art&#233;rielle moyenne (PAM). La pression veineuse centrale (PVC) et la pression d&#8217;occlusion de l&#8217;art&#232;re pulmonaire (POAP) ont augment&#233; significativement dans le groupe P-Rem comparativement aux valeurs de base. En conclusion, les changements h&#233;modynamiques observ&#233;s dans cette &#233;tude indiquent un compromis du syst&#232;me cardio-vasculaire, bien que les chiens utilis&#233;s &#233;taient en sant&#233;/euvol&#233;miques et qu&#8217;il n&#8217;y avait pas de changement dans la pr&#233;charge. Des &#233;tudes suppl&#233;mentaires sont requises afin d&#8217;&#233;valuer la s&#233;curit&#233; de la combinaison de propofol et de remifentanyl chez des patients avec une r&#233;serve cardiaque diminu&#233;e.</p><p>(Traduit par Docteur Serge Messier)</p></trans-abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>